A sustainable chemistry solution to the presence of pharmaceuticals and chemicals in the aquatic environment – the example of re-designing β-blocker Atenolol

Beta-blockers: focus on mechanism of action Which beta-blocker, when and why?

(2017) Frauke Gorre et al.   ACTA CARDIOLOGICA

Designing green derivatives of β-blocker Metoprolol: A tiered approach for green and sustainable pharmacy and chemistry

(2014) Tushar Rastogi et al.   CHEMOSPHERE

Photocatalytic degradation of atenolol in aqueous titanium dioxide suspensions: Kinetics, intermediates and degradation pathways

(2013) Yuefei Ji et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY

Oxidation–coagulation of β-blockers by K2FeVIO4 in hospital wastewater: Assessment of degradation products and biodegradability

(2013) Marcelo L. Wilde et al.   SCIENCE OF THE TOTAL ENVIRONMENT

2D and 3D-QSBR Study on Biodegradation of Phenol Derivatives

(2012) Fuyang Wang et al.   BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY

Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review

(2012) I. Michael et al.   WATER RESEARCH

Pharmaceuticals in the Environment

(2010) Klaus Kümmerer   Annual Review of Environment and Resources

Ozonation of Metoprolol: Elucidation of Oxidation Pathways and Major Oxidation Products

(2009) Jessica Benner et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment

(2009) Lúcia H.M.L.M. Santos et al.   JOURNAL OF HAZARDOUS MATERIALS

Characterization of atenolol transformation products on light-activated TiO2 surface by high-performance liquid chromatography/high-resolution mass spectrometry

(2008) Claudio Medana et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Weighing environmental advantages and disadvantages of advanced wastewater treatment of micro-pollutants using environmental life cycle assessment

(2008) H. Wenzel et al.   WATER SCIENCE AND TECHNOLOGY